Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts

BACKGROUND: The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Tingcai, Chen, Yan, Zhuang, Yuanqi, Yang, Fan, Xu, Yingying, Tao, Jiawang, You, Kai, Wang, Ning, Wu, Yuhang, Lin, Xianhua, Wu, Feima, Liu, Yanli, Li, Yingrui, Wang, Guodong, Li, Yin-xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888929/
https://www.ncbi.nlm.nih.gov/pubmed/31791391
http://dx.doi.org/10.1186/s13287-019-1463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888929/
https://www.ncbi.nlm.nih.gov/pubmed/31791391
http://dx.doi.org/10.1186/s13287-019-1463-y

Ejemplares similares